Victoria Shanmugam, MD, published study on hidradenitis suppurativa in the journal Clinical and Experimental Dermatology.
Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity at the GW Cancer Center, has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and...
A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.
A group of student and faculty researchers from the GW School of Medicine and Health Sciences published outcome of establishing Rheumatology Interest Group in the International Journal of Rheumatology.
Researchers from GW, FDA, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute.
Rohan Fernandes, PhD, received more than $1.6 million from the National Institutes of Health to investigate nanoimmunotherapies for cancer
Members of the GW Cancer Center recently published several journal articles and patient-focused pieces highlighting the Center’s work in patient navigation and survivorship.
For the first time, researchers at the GW School of Medicine and Health Sciences have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which...
Pedro A. Jose, MD, PhD, professor of medicine, received special recognition for his research contributions from Filipino President Rodrigo Duterte.
Researchers at the GW School of Medicine and Health Sciences will look for unknown genes associated with branchiootorenal spectrum disorders.